116 related articles for article (PubMed ID: 3074277)
1. Hepatoprotective and immunomodulatory effects of antioxidant therapy.
Láng I; Deák G; Nékám K; Müzes G; González-Cabello R; Gergely P; Fehér J
Acta Med Hung; 1988; 45(3-4):287-95. PubMed ID: 3074277
[TBL] [Abstract][Full Text] [Related]
2. Hepatoprotective and immunological effects of antioxidant drugs.
Láng I; Nékám K; González-Cabello R; Mũzes G; Gergely P; Fehér J
Tokai J Exp Clin Med; 1990 May; 15(2-3):123-7. PubMed ID: 1983370
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers.
Láng I; Nékám K; Deák G; Müzes G; Gonzales-Cabello R; Gergely P; Csomós G; Fehér J
Ital J Gastroenterol; 1990 Oct; 22(5):283-7. PubMed ID: 1983711
[TBL] [Abstract][Full Text] [Related]
4. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis.
Fehér J; Láng I; Nékám K; Müzes G; Deák G
Acta Med Hung; 1988; 45(3-4):265-76. PubMed ID: 3249654
[TBL] [Abstract][Full Text] [Related]
5. Free radicals in tissue damage in liver diseases and therapeutic approach.
Fehér J; Láng I; Deák G; Cornides A; Nékám K; Gergely P
Tokai J Exp Clin Med; 1986; 11 Suppl():121-34. PubMed ID: 3452238
[TBL] [Abstract][Full Text] [Related]
6. Liver cell protection in toxic liver lesion.
Fehér J; Cornides A; Pál J; Láng I; Csomós G
Acta Physiol Hung; 1989; 73(2-3):285-91. PubMed ID: 2596318
[TBL] [Abstract][Full Text] [Related]
7. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
[TBL] [Abstract][Full Text] [Related]
8. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
[TBL] [Abstract][Full Text] [Related]
9. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
10. In vivo effect of free radical scavenger hepatoprotective agents on superoxide dismutase (SOD) activity in patients.
Fehér J; Láng I; Nékám K; Gergely P; Mũzes G
Tokai J Exp Clin Med; 1990 May; 15(2-3):129-34. PubMed ID: 2130521
[TBL] [Abstract][Full Text] [Related]
11. Effect of (+)cyanidanol-3 on cellular immune reactions and on superoxide dismutase activity in vitro.
Láng I; Nékám K; Deák G; Müzes G; Gonzalez CR; Kádár J; Perl A; Gergely P; Fehér J
Free Radic Res Commun; 1987; 4(1):51-60. PubMed ID: 2976388
[TBL] [Abstract][Full Text] [Related]
12. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F
Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367
[TBL] [Abstract][Full Text] [Related]
13. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
[TBL] [Abstract][Full Text] [Related]
15. Effects of two bioflavonoids on certain cellular immune reactions in vitro.
Deák G; Müzes G; Láng I; Nékám K; González-Cabello R; Gergely P; Fehér J
Acta Physiol Hung; 1990; 76(2):113-21. PubMed ID: 2082690
[TBL] [Abstract][Full Text] [Related]
16. Effect of in vitro Aica-P treatment on certain cellular immune functions.
Deák G; Müzes G; Láng I; Nékám K; González-Cabello R; Gergely P; Fehér J
Acta Physiol Hung; 1990; 76(2):105-11. PubMed ID: 2082689
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
Trinchet JC; Coste T; Lévy VG; Vivet F; Duchatelle V; Legendre C; Gotheil C; Beaugrand M
Gastroenterol Clin Biol; 1989; 13(2):120-4. PubMed ID: 2707520
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of 4-amino-5-imidazole-carboxamide-phosphate (AICA-P) on the enzyme activity and expression of superoxide dismutase.
Müzes G; Deák G; Láng I; Nékám K; Gergely P; Fehér J
Acta Physiol Hung; 1990; 76(3):183-90. PubMed ID: 2100099
[TBL] [Abstract][Full Text] [Related]
19. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)].
Magliulo E; Gagliardi B; Fiori GP
Med Klin; 1978 Jul; 73(28-29):1060-5. PubMed ID: 353464
[TBL] [Abstract][Full Text] [Related]
20. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
Busin S; Micheli PL; Sovera A
Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
